Joseph Masanja

Joseph is a clinician with a postgraduate training in Public Health. He is a Deputy Trial Manager of the cluster randomized clinical trial (Add-Vacc) aiming to assess the impact of adding male HPV vaccination with one dose of HPV vaccine alongside the Tanzanian national HPV vaccination programme on the population prevalence of HPV vaccine genotypes in both males and females. The results of this trial will help to guide future HPV vaccination policy in Tanzania where HPV vaccination is currently delivered to girls only.

Joseph has extensive research experience, having previously worked in MITU as a coordinator of a multicenter clinical trial to test the efficacy of candidate microbicide products for prevention of HIV among women at increased risk of HIV infection in Mwanza city.  This was part of the Microbicide Development Program (MDP 301) funded by the UK government, and including research sites in Uganda, Zambia, South Africa and Mozambique. Before this trial, Joseph spent about 15 years working in a range of research projects implemented as part of the collaboration between Africa Medical Research Foundation (Amref), National Institute for Medical Research (NIMR) and the London School of Hygiene and Tropical Medicine (LSHTM).